Janssen Biotech, Inc.
Summary
Janssen Biotech, Inc. is registered in the United States and entered in the “Business Search” under number 675202. Its legal form is Business Corporation (corp.). According to GLEIF, its ultimate parent is Johnson & Johnson (United States), which is also its direct parent. That group has 209 subsidiaries with LEIs in 47 countries, 55 of them in the United States. The LEI was first issued on 3 Apr 2013 and the record was last updated on 15 Jul 2026; the next renewal is due by 19 Jul 2027. GLEIF's ISIN mapping lists 2 ISINs for this LEI.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | Business Corporation (corp.) |
|---|---|
| Register | Business Search · Register website |
| Registration number | 675202 |
| Registration authority | Pennsylvania Department of State |
| Jurisdiction | United States (US-PA) |
| Registered address | C/O CT Corporation System, 600 North Second Street, 17101 Harrisburg, United States |
| Headquarters address | 800/850 Ridgeview Drive, 19044 HORSHAM, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 16 May 1979 |
| LEI | 549300N03XQR27RJXA70 |
| LEI status | active |
| LEI first issued | 3 Apr 2013 |
| LEI record last updated | 15 Jul 2026 |
| Next LEI renewal | 19 Jul 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Johnson & Johnson | Johnson & Johnson |
| Accounting period | 1 Jan 2024 to 31 Dec 2024 | 1 Jan 2024 to 31 Dec 2024 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Relationship start | 16 May 1979 | 16 May 1979 |
| Recorded at GLEIF since | 31 May 2024 | 31 May 2024 |
| Last updated | 24 Jul 2025 | 24 Jul 2025 |
| Record status | current | current |
Other subsidiaries of the same direct parent (97)
- ACCLARENT, INC. United States
- ACTELION PHARMACEUTICALS US, INC. United States lapsed
- ALZA CORPORATION United States
- AMO HOLDINGS, INC. United States lapsed
- AMO SALES AND SERVICE, INC. United States
- AURIS HEALTH, INC. United States
- BIOMEDICAL ENTERPRISES, INC. United States lapsed
- BIOSENSE WEBSTER, INC. United States
- CORDIS FINANCING CORPORATION United States lapsed
- DEPUY SYNTHES PRODUCTS, INC. United States
- DEPUY SYNTHES SALES, INC. United States
- DEPUY SYNTHES, INC. United States
ISINs mapped to this LEI (2)
US1523421014 · US1523421352
2 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.
Other names
- HYBRIDOMAS INCORPORATED · previous name
- Centocor Ortho Biotech Inc. · previous name
- CENTOCOR, INC. · previous name